2020
Essential Information on Surgical Heart Valve Characteristics for Optimal Valve Prosthesis Selection: Expert Consensus Document From the European Association for Cardio-Thoracic Surgery (EACTS)–The Society of Thoracic Surgeons (STS)–American Association for Thoracic Surgery (AATS) Valve Labelling Task Force
Durko AP, Pibarot P, Atluri P, Bapat V, Cameron D, Casselman FPA, Chen EP, Dahle G, Elefteriades JA, Lancellotti P, Prager RL, Rosenhek R, Speir A, Stijnen M, Tasca G, Yoganathan A, Walther T, De Paulis R, Force ;, De Paulis R, Atluri P, Bapat V, Cameron D, Casselman F, Chen E, Dahle G, Durko A, Elefteriades J, Prager R, Speir A, Tasca G, Walther T, Lancellotti P, Pibarot P, Rosenhek R, de Hart J, Stijnen M, Yoganathan A, Ibrahim N, Laschinger J, Wu C, Di Rienzo G, McLaren A, Randall H, Becker L, Capps S, Duncan B, Green C, Hay J, Head S, Ieropoli O, Jacob A, Kappetein A, Manasse E, Marquez S, Northrup W, Ryan T, Smith W. Essential Information on Surgical Heart Valve Characteristics for Optimal Valve Prosthesis Selection: Expert Consensus Document From the European Association for Cardio-Thoracic Surgery (EACTS)–The Society of Thoracic Surgeons (STS)–American Association for Thoracic Surgery (AATS) Valve Labelling Task Force. The Annals Of Thoracic Surgery 2020, 111: 314-326. PMID: 33036738, DOI: 10.1016/j.athoracsur.2020.05.060.Peer-Reviewed Original ResearchMeSH KeywordsDecision TreesHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansProsthesis DesignConceptsSurgical heart valves
1987
Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
Kopf G, Hammond G, Geha A, Elefteriades J, Hashim S. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Circulation 1987, 76: iii132-6. PMID: 3621536.Peer-Reviewed Original ResearchConceptsSt. Jude Medical valveJude Medical valveModest dosesHemorrhagic complicationsLower incidenceValve failureLate cardiac deathStructural valve failureDouble valve replacementPercent of patientsOccurrence of thromboembolismHospital survivorsAnticoagulation regimenPerivalvular leakValve thrombosisValve replacementCardiac deathProthrombin timeMitral positionThromboembolismPatientsComplicationsThrombosisWarfarinIncidence